Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans